Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2026-06-30 @ 2:12 PM
Study NCT ID:
NCT04951050
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-09
First Post:
2021-06-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment
Sponsor:
Shanghai MicroPort Medical (Group) Co., Ltd.
Organization: